PREVALENCE OF ANXIETY DISORDERS IN HAIR LOSS PATIENTS AT CAN THO DERMATOLOGY HOSPITAL
Main Article Content
Abstract
Background: Alopecia is a prevalent dermatological condition that, although not lifethreatening, can exert a significant psychological impact—most notably in the form of anxiety disorders. While numerous international studies have established an association between hair loss and anxiety, evidence from Vietnam remains scarce. The Generalized Anxiety Disorder-7 (GAD-7) scale serves as a rapid and validated instrument for the screening and assessment of anxiety symptoms.Objective: To determine the prevalence and severity of anxiety disorders and to identify associated factors among patients with alopecia. Materials and method: A crosssectional descriptive study was conducted on 81 patients diagnosed with alopecia at Can Tho Dermatology Hospital between July 2024 and April 2025. Alopecia was clinically diagnosed, and the severity of anxiety was evaluated using the GAD-7 scale. Demographic characteristics, alopecia subtypes, and clinical parameters were collected and statistically analyzed. Results: The mean age of participants was 31.12±10.70 years; 51.9% were female, and 54.3% resided in rural areas. Alopecia areata was the predominant subtype (71.6%), followed by androgenetic alopecia (18.5%) and other non-scarring alopecias (9.9%). The overall prevalence of anxiety disorders was 30.9%, with the highest rate observed in patients with alopecia areata (37.9%). Female gender was identified as an independent risk factor for anxiety (p=0.001). Female gender and a disease duration of ≤ 6 months were associated with a higher risk of anxiety and were identified as independent risk factors (p=0.009 and p=0.014, respectively). Conclusion: Anxiety disorders are relatively common among patients with alopecia, particularly among female individuals. Comprehensive patient management should incorporate both dermatological treatment and systematic psychological evaluation and support.
Keywords
Hair loss, anxiety disorder, GAD-7 scale
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
2. Yu Linli, Moorthy SathishKumar, Peng Lin, Shen Liangliang, Han Yu, et al. Evaluation of anxiety and depression in patients with androgenetic alopecia in Shanghai: a cross‐sectional study. Dermatologic Therapy. 2023. 2023 (1), 5140620, DOI: 10.1155/2023/5140620.
3. Arck Petra C, Slominski Andrzej, Theoharides Theoharis C, Peters Eva MJ, Paus Ralf. Neuroimmunology of stress: skin takes center stage. Journal of Investigative Dermatology. 2006. 126 (8), 1697-1704.
4. Ruiz Miguel A, Zamorano Enric, García-Campayo Javier, Pardo Antonio, Freire Olga, et al. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. Journal of affective disorders. 2011. 128 (3), 277-286, DOI: 10.1016/j.jad.2010.07.010.
5. Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị các bệnh da liễu. Quyết định số. 2023. 75, 446-455,
6. Mandelin J. M., Rehn L., Kosunen M., Väkeväinen M., Rannanpää S. The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland. J Patient Exp. 2025. 12, 23743735251346633, DOI: 10.1177/23743735251346633.
7. World Health Organization. International statistical classification of diseases and related health problems (10th revision). World Health Organization. 2019.
8. Spitzer Robert L., Kroenke Kurt, Williams Janet B. W., Löwe Bernd. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Archives of Internal Medicine. 2006. 166 (10), 1092-1097, DOI: 10.1001/archinte.166.10.1092.
9. Lauron Sophie, Plasse Camille, Vaysset Marion, Pereira Bruno, D’Incan Michel, et al. Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata: A Systematic Review and Meta-analysis. JAMA Dermatology. 2023. 159 (3), 281-288, DOI: 10.1001/jamadermatol.2022.6085.
10. Kong Y., Shang Y., Zhang L. Association between androgenetic alopecia and psychological well-being: a systematic review and meta-analysis. Front Psychiatry. 2025. 16, 1705957, DOI: 10.3389/fpsyt.2025.1705957.
11. Williamson Daniel, Gonzalez Marc, Finlay Andrew Yule. The effect of hair loss on quality of life. Journal of the European Academy of Dermatology and Venereology. 2001. 15 (2), 137139, DOI: 10.1046/j.1468-3083.2001.00229.x.
12. Marije van Dalen, Muller Kirsten S, Kasperkovitz-Oosterloo Johanna M, Okkerse Jolanda ME, Pasmans Suzanne GMA. Anxiety, depression, and quality of life in children and adults with alopecia areata: a systematic review and meta-analysis. Frontiers in Medicine. 2022. 9, 1054898, DOI: 10.3389/fmed.2022.1054898.
13. Kashaninasab Fatemeh, Bandi Mir Farhad Ghaleh, Ghazvini Azim, Goodarzi Azadeh, Moudi Sussan, et al. The Quality of Sleep and Quality of Life in Patients with Alopecia. Journal of Sleep sciences. 2020. DOI: 10.18502/jss.v5i2.5609.